Michelle L. Basil

2022

In 2022, Michelle L. Basil earned a total compensation of $3.4M as Executive Vice President, General Counsel at Haemonetics, a 58% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$293,193
Option Awards$349,982
Salary$477,619
Stock Awards$2,241,162
Other$17,778
Total$3,379,734

Basil received $2.2M in stock awards, accounting for 66% of the total pay in 2022.

Basil also received $293.2K in non-equity incentive plan, $350K in option awards, $477.6K in salary and $17.8K in other compensation.

Rankings

In 2022, Michelle L. Basil's compensation ranked 1,066th out of 5,736 executives tracked by ExecPay. In other words, Basil earned more than 81.4% of executives.

ClassificationRankingPercentile
All
1,066
out of 5,736
81st
Division
Manufacturing
501
out of 3,125
84th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
55
out of 485
89th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
36
out of 347
90th
Industry
Surgical and Medical Instruments and Apparatus
29
out of 253
89th

Pay ratio

Michelle L. Basil's Pay$3,379,734
Median Employee's Pay$45,323
Pay Ratio

75

to 1

In 2022, the annual total compensation of Michelle L. Basil was $3,379,734.

The annual total compensation of the median employee at Haemonetics was $45,323.

The ratio of Michelle L. Basil's pay to the pay of median employee was therefore 75 to one.

Source: SEC filing on June 17, 2022.

Basil's colleagues

We found four more compensation records of executives who worked with Michelle L. Basil at Haemonetics in 2022.

2022

Christopher Simon

Haemonetics

Chief Executive Officer

2022

William Burke

Haemonetics

Chief Financial Officer

2022

Stewart Strong

Haemonetics

President, Global Hospital

2022

Josep Llorens

Haemonetics

Executive Vice President, Global Manufacturing and Supply Chain

News

You may also like